Biosergen AB (publ) (STO:BIOSGN)
Sweden
· Delayed Price · Currency is SEK 37.00
-1.00 (-2.63%)
Mar 9, 2026, 2:38 PM CET
Biosergen AB Market Cap
Biosergen AB has a market cap or net worth of 89.23 million as of March 9, 2026. Its market cap has decreased by -9.95% in one year.
Market Cap
89.23M
Enterprise Value
73.86M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
37.00
Market Cap Chart
Since June 24, 2021, Biosergen AB's market cap has decreased from 197.72M to 89.23M, a decrease of -54.87%. That is a compound annual growth rate of -15.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 86.88M | -6.38% |
| Dec 30, 2025 | 92.80M | -25.43% |
| Dec 30, 2024 | 124.46M | 179.03% |
| Dec 29, 2023 | 44.60M | 0.12% |
| Dec 30, 2022 | 44.55M | -70.75% |
| Dec 30, 2021 | 152.31M | -22.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scandinavian ChemoTech AB | 88.33M |
| OncoZenge AB | 85.83M |
| Spago Nanomedical AB | 83.36M |
| Biovica International AB | 96.33M |
| Annexin Pharmaceuticals AB | 102.36M |
| Alligator Bioscience AB | 104.66M |
| Active Biotech AB | 118.89M |
| Xbrane Biopharma AB | 123.41M |